No paralogue variants have been mapped to residue 166 for KCNQ1.
| KCNQ1 | ------------ALATGT-LF-WMEIVLVV>F<FGTEYVVRLWSAGCRSKYVGLWGRLRFARK | 196 |
| KCNQ2 | ------------KSSEGA-LY-ILEIVTIV>V<FGVEYFVRIWAAGCCCRYRGWRGRLKFARK | 166 |
| KCNQ3 | ------------TVSGDW-LL-LLETFAIF>I<FGAEFALRIWAAGCCCRYKGWRGRLKFARK | 196 |
| KCNQ4 | ------------ELANEC-LL-ILEFVMIV>V<FGLEYIVRVWSAGCCCRYRGWQGRFRFARK | 172 |
| KCNQ5 | ------------KLASSC-LL-ILEFVMIV>V<FGLEFIIRIWSAGCCCRYRGWQGRLRFARK | 200 |
| KCNA1 | ----NTTVIYNSNIFTDP-FF-IVETLCII>W<FSFELVVR---------FFACPSKTDFFKN | 252 |
| KCNA10 | ---NMSKTVLSQTMFTDP-FF-MVESTCIV>W<FTFELVLR---------FVVCPSKTDFFRN | 302 |
| KCNA2 | ---NSTIGYQQSTSFTDP-FF-IVETLCII>W<FSFEFLVR---------FFACPSKAGFFTN | 253 |
| KCNA3 | ---STSGSRAGASSFSDP-FF-VVETLCII>W<FSFELLVR---------FFACPSKATFSRN | 326 |
| KCNA4 | ---APHLENSGHTIFNDP-FF-IVETVCIV>W<FSFEFVVR---------CFACPSQALFFKN | 402 |
| KCNA5 | ---GPTVAPLLPRTLADP-FF-IVETTCVI>W<FTFELLVR---------FFACPSKAGFSRN | 355 |
| KCNA6 | TGGSSSLSTLGGSFFTDP-FF-LVETLCIV>W<FTFELLVR---------FSACPSKPAFFRN | 294 |
| KCNA7 | ---SQMPGNPPRLPFNDP-FF-VVETLCIC>W<FSFELLVR---------LLVCPSKAIFFKN | 240 |
| KCNB1 | -------------STDNPQLA-HVEAVCIA>W<FTMEYLLR---------FLSSPKKWKFFKG | 260 |
| KCNB2 | -------------LNDNRQLA-HVEAVCIA>W<FTMEYLLR---------FLSSPNKWKFFKG | 264 |
| KCNC1 | ---NGTQVRYYREAETEA-FLTYIEGVCVV>W<FTFEFLMR---------VIFCPNKVEFIKN | 276 |
| KCNC2 | ---NGTSVVLQYEIETDP-ALTYVEGVCVV>W<FTFEFLVR---------IVFSPNKLEFIKN | 313 |
| KCNC3 | ---APPENITNVEVETEP-FLTYVEGVCVV>W<FTFEFLMR---------ITFCPDKVEFLKS | 379 |
| KCNC4 | ---NITSVHFRREVETEP-ILTYIEGVCVL>W<FTLEFLVR---------IVCCPDTLDFVKN | 312 |
| KCND1 | -------EQPCGERFPQA-FF-CMDTACVL>I<FTGEYLLR---------LFAAPSRCRFLRS | 262 |
| KCND2 | -------ELPCGERYAVA-FF-CLDTACVM>I<FTVEYLLR---------LAAAPSRYRFVRS | 260 |
| KCND3 | -------ELPCGERYSVA-FF-CLDTACVM>I<FTVEYLLR---------LFAAPSRYRFIRS | 257 |
| KCNF1 | -------------RVEHPTLE-NVETACIG>W<FTLEYLLR---------LFSSPNKLHFALS | 253 |
| KCNG1 | ------------SQMCHN-VF-IVESVCVG>W<FSLEFLLR---------LIQAPSKFAFLRS | 299 |
| KCNG2 | ------------SPKCRS-LF-VLETVCVA>W<FSFEFLLR---------SLQAESKCAFLRA | 249 |
| KCNG3 | ----DDRSRYSAGPGREP-SG-IIEAICIG>W<FTAECIVR---------FIVSKNKCEFVKR | 252 |
| KCNG4 | ------------SRKCYY-IF-IVETICVA>W<FSLEFCLR---------FVQAQDKCQFFQG | 293 |
| KCNS1 | ---AVAAGRSPEGVRDDPVLR-RLEYFCIA>W<FSFEVSSR---------LLLAPSTRNFFCH | 303 |
| KCNS2 | -------------PGEDPRFE-IVEHFGIA>W<FTFELVAR---------FAVAPDFLKFFKN | 258 |
| KCNS3 | --------------VDDPVLE-GVEIACIA>W<FTGELAVR---------LAAAPCQKKFWKN | 253 |
| KCNV1 | -------------WLDLQLLE-ILEYVCIS>W<FTGEFVLR---------FLCVRDRCRFLRK | 273 |
| KCNV2 | ------------GPDLRPILE-HVEMLCMG>F<FTLEYLLR---------LASTPDLRRFARS | 333 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.F166V | c.496T>G | Putative Benign | SIFT: Polyphen: |